Cynata Therapeutics Limited (AU:CYP) has released an update.
Cynata Therapeutics Limited, an Australian biotech firm, is set to showcase its developments in cell therapy at the International Society of Cell and Gene Therapy Annual Meeting in Vancouver. The company’s CEO, Dr. Kilian Kelly, will discuss successful clinical trial setups and present on the clinical development of Cynata’s proprietary Cymerus™ technology for stem cell therapies. Cynata’s innovative platform is designed to enable the economical production of therapeutic stem cells at a commercial scale.
For further insights into AU:CYP stock, check out TipRanks’ Stock Analysis page.
